September 10, 2025Frontiers in NutritionOpen Access

EAT-Lancet diet and risk of metabolic dysfunction-associated steatotic liver disease and other liver chronic diseases: a large prospective cohort study in the UK Biobank

View Full Paper

Ask AI

Bookmark

A 33% reduction in MASLD incidence was observed in participants adhering to the EAT-Lancet diet.
Among the highest EAT-Lancet diet index group, the HR for MASLD was 0.67, indicating significant protective effects.
The study included 160,394 participants from the UK Biobank and utilized Cox proportional hazards models to analyze data.
Adherence to the EAT-Lancet diet may help mitigate chronic liver disease risk, independent of genetic predispositions.

Discussion

No takes yet. Share an insight, caveat, or question.

Prospective cohort study suggests the EAT-Lancet diet reduces MASLD incidence in participants, highlighting its health benefits.

Wu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark